Related Experiment Video
Updated: Jun 11, 2026
13:01
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Acute seronegative autoimmune hepatitis.
Ersan Ozaslan1, Ufuk Samsar, Esra Erden
1Numune Education and Training Hospital, Department of Gastroenterology, Ankara, Turkey. er72@hotmail.com
Hepato-Gastroenterology
|June 30, 2010
Summary
This case study highlights a 52-year-old woman with atypical autoimmune hepatitis. Despite negative autoimmune markers and acute presentation with necrosis, she achieved full recovery with immunosuppressive therapy.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Autoimmune hepatitis (AIH) is a chronic liver disease characterized by autoimmune లక్షణాలు.
- Typical AIH diagnosis relies on serological markers and histological findings.
- Atypical presentations of AIH can pose diagnostic challenges.
Observation:
- A 52-year-old woman presented with acute liver injury.
- She exhibited atypical features, including negative autoimmune markers.
- Histopathology revealed multiple acinar confluent necrosis, an unusual finding in AIH.
Findings:
- The patient's presentation mimicked other causes of acute liver failure.
- Despite the absence of typical autoimmune markers, AIH was suspected due to the clinical context.
- Histological evidence of confluent necrosis was a key observation.
Implications:
- This case underscores the importance of considering AIH even with atypical serological results.
- Early diagnosis and prompt immunosuppressive therapy are crucial for favorable outcomes in AIH.
- Further research into the spectrum of AIH presentations and diagnostic criteria may be warranted.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:17Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...